Article
EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma.
Journal of cancer research and clinical oncology - 1 Aug 2012
Yu Yongfeng, Song Zhengbo, Gao Hui, Zhu Lei, Lu Shun, Zhang Jie, Luo Qingquan
Abstract excerpt
PURPOSE: The purpose of this study is to assess the feasibility of targeted treatment for pulmonary mucoepidermoid carcinoma (PMEC) by investigating track record of the epidermal growth factor receptor (EGFR) mutation status in PMEC. METHODS: From January 2001 to December 2009, 20 PMEC patients (11 males and 9 females) received treatment in our center. All the patients received surgery and were diagnosed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
